Company / Net Income
Tango Therapeutics, Inc. Net Income History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$101.6M
FY2025
5-year range
-$130.3M / -$52.0M
FY2021-FY2025
Trend
+22.0%
vs FY2024
Sector context
#110 of 216
Health Care
What the data says
At -$102M, Tango Therapeutics, Inc.'s net income ranks #110 of 216 in the Health Care sector. Net Income returned to growth in FY2025 after 3 years of decline, reaching -$102M.
Based on SEC 10-K filings.
-$102M in FY2025.
Remained stable around -$102M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#110 of 216 in Health CareTop 51% of 216This company -$101.6M Sector average $454.3M
▼
-122.4% below sector average
Key checks
Key Insights
- In FY2025, net income increased 22.0% year-over-year.
- Ranks #110 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2021.
- Lowest net income in the period was in FY2024.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$101.6M | +22.0% |
| FY2024 | -$130.3M | -28.1% |
| FY2023 | -$101.7M | -74.7% |
| FY2022 | -$58.2M | -12.1% |
| FY2021 | -$52.0M | +0.0% |
| FY2020 | -$52.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026